BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.58
-0.02%
US Tech 100
20,383.60
0.59%
S&P 500
6,021.63
0.57%
US Dollar vs CAD
1.4056
-0.19%
Bitcoin
91,691.46
-1.50%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Iovance Biotherapeutics Inc (0JDK)

  7. Iovance Biotherapeutics Inc (0JDK) Financials

Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc (0JDK)

LSE
16.25
0.00
(0.00%)
Closed November 26 10:30AM
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 171.89M155.37M480.82M344.66M768.46M777.33M663.98M780.35M
Total Current Assets 169.51M149.29M475.37M316.49M636.1M507.96M479.12M307.85M
Cash and Equivalents 106.72M145.37M82.15M13.97M67.33M78.23M231.73M114.89M
Total Non-Current Assets 166.92M145.48M466.19M298.97M656.5M621.66M499.64M584.61M
Total Liabilities 4.97M9.89M14.63M45.68M111.96M155.67M164.34M195.74M
Total Current Liabilities 4.97M9.89M14.4M39.08M54.87M89.2M91.49M110.31M
Total Non-Current Liabilities 00230k6.6M57.09M67.47M73.86M86.43M
Total Equity 166.92M145.48M466.19M298.97M656.5M621.66M499.64M584.61M
Common Equity 11k10k11k9k10k10k11k14k
Retained Earnings -157.12M-249.18M-372.76M-570.61M-830.19M-1.17B-1.57B-2.01B

Your Recent History

LSE
0JDK
Iovance Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68